Dong Lin

1.3k total citations
67 papers, 714 citations indexed

About

Dong Lin is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Dong Lin has authored 67 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 18 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Dong Lin's work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Dong Lin is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Dong Lin collaborates with scholars based in China, United States and Hong Kong. Dong Lin's co-authors include Qing Yu, Yan Li, Jianxiang Wang, Lin Yang, Xiaoting Ma, Xiu Liu, Yingchang Mi, Yujing Bi, Jianming Ying and Ying He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Dong Lin

59 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Lin China 14 263 195 186 134 130 67 714
Massimo Masiero Italy 16 405 1.5× 192 1.0× 157 0.8× 78 0.6× 87 0.7× 23 806
Maria Melachrinou Greece 17 231 0.9× 93 0.5× 166 0.9× 52 0.4× 118 0.9× 54 722
Jamil Dierov United States 11 412 1.6× 72 0.4× 161 0.9× 182 1.4× 144 1.1× 15 733
Takakazu Sasaguri Japan 16 217 0.8× 83 0.4× 183 1.0× 42 0.3× 142 1.1× 40 777
Stefan Wilop Germany 21 631 2.4× 130 0.7× 237 1.3× 377 2.8× 89 0.7× 48 1.1k
Jan Hörstrup Germany 9 374 1.4× 523 2.7× 89 0.5× 69 0.5× 63 0.5× 11 968
Anthoula Chatzikyriakidou Greece 13 244 0.9× 210 1.1× 68 0.4× 45 0.3× 168 1.3× 40 780
Marianne Bach Treppendahl Denmark 16 496 1.9× 123 0.6× 97 0.5× 257 1.9× 124 1.0× 24 832
Roeliene C. Kruizinga Netherlands 13 253 1.0× 174 0.9× 555 3.0× 81 0.6× 322 2.5× 14 1.1k
Lingyun Wu China 18 441 1.7× 111 0.6× 137 0.7× 571 4.3× 137 1.1× 62 971

Countries citing papers authored by Dong Lin

Since Specialization
Citations

This map shows the geographic impact of Dong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Lin more than expected).

Fields of papers citing papers by Dong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Lin. The network helps show where Dong Lin may publish in the future.

Co-authorship network of co-authors of Dong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Lin. A scholar is included among the top collaborators of Dong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Lin. Dong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ran, Haitao, Jianmin Huang, Dong Lin, et al.. (2025). Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1382–A1382. 2 indexed citations
2.
Huang, Jianyong, Dong Lin, Di Liu, et al.. (2025). AI-guided Engineering and Generation of Bispecific Antibodies Targeting Both IL13 and TSLP for Chronic Respiratory Diseases. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1361–A1361. 1 indexed citations
3.
Ran, Haitao, Dongyang Liu, Yuwei Zhou, et al.. (2025). AI-guided Generation and Development of HXN-1011, A Highly Potent Anti-TSLP Biparatopic Antibody. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7443–A7443. 1 indexed citations
4.
Huang, Jianyong, Hao Ran, Xintong Zhang, et al.. (2025). P1114 Engineering and Development of a Novel Bispecific Antibody Targeting IL-23 and TL1A. Journal of Crohn s and Colitis. 19(Supplement_1). i2046–i2046. 2 indexed citations
5.
Liu, Wenbing, Hui Wei, Ying Wang, et al.. (2024). The RTK–RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/FUS::ERG. SHILAP Revista de lepidopterología. 6(2). e00188–e00188. 2 indexed citations
6.
Li, Jiayi, et al.. (2024). DNA damage response in breast cancer and its significant role in guiding novel precise therapies. Biomarker Research. 12(1). 111–111. 8 indexed citations
7.
Gong, Xiaoyuan, Runxia Gu, Shaowei Qiu, et al.. (2024). A pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China. Haematologica. 109(10). 3146–3156. 7 indexed citations
8.
Li, Jialiang, Suxia Luo, Tianbo Liu, et al.. (2023). 684P Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC). Annals of Oncology. 34. S478–S478. 8 indexed citations
9.
Ye, Liang, Xiaoyan Gong, Dong Lin, et al.. (2023). Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats. Frontiers in Pharmacology. 14. 1125255–1125255. 1 indexed citations
11.
Liu, Yisi, et al.. (2020). CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1. SHILAP Revista de lepidopterología. 5 indexed citations
12.
Gong, Xiaoyuan, Dong Lin, Hui Wei, et al.. (2020). CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020003–e2020003. 3 indexed citations
13.
Yu, Qing, Yufei Wang, Dong Lin, et al.. (2020). Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation. Frontiers in Cellular and Infection Microbiology. 10. 287–287. 65 indexed citations
14.
Lin, Dong, Wenmiao Wang, Qiurong Ye, et al.. (2020). Distinct clinical phenotype and genetic testing strategy for Lynch syndrome in China based on a large colorectal cancer cohort. International Journal of Cancer. 146(11). 3077–3086. 15 indexed citations
15.
Gu, Runxia, Hui Wei, Ying Wang, et al.. (2017). The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia. PLoS ONE. 12(7). e0180624–e0180624. 2 indexed citations
16.
18.
Zhang, Yiqun, Hui Wei, Kejing Tang, et al.. (2012). Mutation Analysis of Isocitrate Dehydrogenase in Acute Lymphoblastic Leukemia. Genetic Testing and Molecular Biomarkers. 16(8). 991–995. 22 indexed citations
19.
Lin, Dong. (2004). A PRELIMINARY STUDY OF THE EARLY PERMIAN LONGLINIAN FUSULINACEAN BIOSTRATIGRAPHY FROM ZONGDI SECTION, ZIYUN COUNTY, GUIZHOU PROVINCE. Dicengxue zazhi. 1 indexed citations
20.
Lin, Dong. (2002). A Mouse Model with Hematopoietic Stem Cell Failure Induced by Myleran and Determination of Lymphocyte Transform Function.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026